Melissa Christine Holt

Melissa Christine Holt is a Senior Research Scientist at Odyssey Therapeutics since May 2022, with prior experience as a Scientist in Medicinal Chemistry at Pfizer from January 2020 to May 2022, focusing on oncology drug discovery. Previous roles at Cayman Chemical included Scientist I in Medicinal Chemistry and Structural Biology Services, where responsibilities involved synthetic organic chemistry, computational chemistry, and managing drug discovery programs. Melissa's academic background includes a Master of Science in Medicinal Chemistry and a Bachelor of Science in Biochemistry from the University of Michigan, where research involved antibiotic targets in Gram-negative bacteria and the Mycobacterium tuberculosis transcription complex.